KAYLA EVERSOLE: Open Payments
NPI 1003420795 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 4 payments from 4 companies in 2025. Trend: 2023 $1,195 · 2024 $361 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 1 | $122 |
| GlaxoSmithKline, LLC. | 1 | $60 |
| Smith+Nephew, Inc. | 1 | $59 |
| GENZYME CORPORATION | 1 | $25 |
Products named: Xhance, NUCALA, TULA, DUPIXENT.
Industry payments across OR — which companies pay providers there.
